LH
US self-pay prices

Lemonaid Health GLP-1 prices

Telehealth

Telehealth with a $49 monthly membership; the medication is billed separately (compounded semaglutide and tirzepatide, Zepbound vials through LillyDirect, brand Ozempic and Wegovy). Lemonaid Health has 5 sourced self-pay GLP-1 offers here. Advertised entry prices: Compounded semaglutide $348/mo ($299 medication + $49 ongoing membership/provider fee); Compounded tirzepatide $348/mo ($299 medication + $49 ongoing membership/provider fee); Ozempic $1,248/mo ($1,199 medication + $49 ongoing membership/provider fee); Wegovy $1,648/mo ($1,599 medication + $49 ongoing membership/provider fee); Zepbound vials $348/mo ($299 medication + $49 ongoing membership/provider fee). Compounded products are not FDA-approved. Plan terms, fees and the check date are listed with each quote.

Semaglutide · Compounded

1 offers · US self-pay

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.

The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.

Lemonaid Health microdose plans

Low-dose plans Lemonaid Health sells apart from its regular plans. They are compounded, not FDA-approved, and priced for a dose below the maintenance doses on the FDA labels.

  • Microdose semaglutide: $248/mo. Calculated: $199 medication + $49 ongoing membership/provider fee. Monthly; the $49 membership is required. Checked Oct 19, 2026, source (Lemonaid Health microdose price source).Regular plan: $348/mo.
  • Microdose tirzepatide: $248/mo. Calculated: $199 medication + $49 ongoing membership/provider fee. Monthly; doses capped at 25% of the standard maintenance dose; the $49 membership is required. Checked Oct 19, 2026, source (Lemonaid Health microdose price source).Regular plan: $348/mo.
Compare microdose prices at every seller
Questions

Lemonaid Health GLP-1 cost: common questions

How much does semaglutide cost through Lemonaid Health?

Compounded semaglutide: $348/mo ($299 medication + $49 ongoing membership/provider fee). Ozempic: $1,248/mo ($1,199 medication + $49 ongoing membership/provider fee). Wegovy: $1,648/mo ($1,599 medication + $49 ongoing membership/provider fee). Checked Oct 17, 2026; each quote links its source in the table. Compounded semaglutide is not an FDA-approved product.

How much does tirzepatide cost through Lemonaid Health?

Compounded tirzepatide: $348/mo ($299 medication + $49 ongoing membership/provider fee). Zepbound vials: $348/mo ($299 medication + $49 ongoing membership/provider fee). Checked Oct 17, 2026; each quote links its source in the table. Compounded tirzepatide is not an FDA-approved product.

Does Lemonaid Health offer FDA-approved GLP-1 medication or compounded versions?

Both are tracked here. FDA-approved products: Ozempic; Wegovy; Zepbound vials. Compounded: Compounded semaglutide; Compounded tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.

Do Lemonaid Health prices include the medication?

The totals shown here add the medication price and the provider's own fee. Compounded semaglutide: $348/mo ($299 medication + $49 ongoing membership/provider fee). Compounded tirzepatide: $348/mo ($299 medication + $49 ongoing membership/provider fee). Ozempic: $1,248/mo ($1,199 medication + $49 ongoing membership/provider fee). Wegovy: $1,648/mo ($1,599 medication + $49 ongoing membership/provider fee). Zepbound vials: $348/mo ($299 medication + $49 ongoing membership/provider fee).

When were Lemonaid Health prices last checked?

Each quote carries its own check date and links the page it was read from: Oct 17, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

How much does Lemonaid Health's microdose GLP-1 cost?

Lemonaid Health's microdose semaglutide: $248/mo. Calculated: $199 medication + $49 ongoing membership/provider fee. Monthly; the $49 membership is required. By comparison, its regular compounded semaglutide plan is $348/mo. Checked Oct 19, 2026. Lemonaid Health's microdose tirzepatide: $248/mo. Calculated: $199 medication + $49 ongoing membership/provider fee. Monthly; doses capped at 25% of the standard maintenance dose; the $49 membership is required. By comparison, its regular compounded tirzepatide plan is $348/mo. Checked Oct 19, 2026. Microdose GLP-1 prices at every seller

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.